U.S. Pharmacist Weekly News Update
August 29, 2019

Too-Intensive Diabetes Treatment Surprisingly Common in United States
Intensive glucose-lowering therapy, especially among clinically complex patients, can be extremely dangerous and affects as many as 2.3 million adults in the United States, according to a new study. Find out how many diabetes patients visit the emergency department or are hospitalized because of drug-induced hypoglycemia.


Despite Guidelines, As-Needed Steroids Keep Mild Asthma

A new study suggests it may be time for an adjustment to the traditional protocol for treatment of mild childhood asthma by using a steroid inhaler daily and adding a bronchodilator when symptoms occur. Here is more information about what researchers discovered regarding as-needed use of both inhalers.

Osteoporosis Drugs Found to Reduce Premature Death Risks
in Older Adults

Patients sometimes are resistant to initiating bisphosphonate treatment for osteoporosis. A new study should help pharmacists and other healthcare professionals promote the benefits, however. Find out how much the drugs reduced premature death risk in older adults.

Intensive BP Control Slows
Brain-Lesion Accumulation
Versus Standard Treatment

When it comes to antihypertension medications and brain health, more appears to be better. Find out how much intensive blood pressure (BP) control slowed the accumulation of white-matter lesions in the brain compared with standard treatment in a SPRINT substudy.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App